Evidence map›Paper›PMID 41199965›Full record

ArticleAnnals of gastroenterological surgery2025

Association Between the Degree of Arterial Contact Angle and Survival in Patients With Borderline Resectable Pancreatic Cancer.

Katsuhisa Ohgi, Ryo Ashida, Mihoko Yamada, Shimpei Otsuka, Yoshiyasu Kato, Rui Sato, Akifumi Notsu, Katsuhiko Uesaka, Teiichi Sugiura

Abstract read
In one paragraph

Article in Annals of gastroenterological surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katsuhisa OhgiDivision of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan.
Ryo AshidaDivision of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan.ORCID https://orcid.org/0000-0001-8388-0135
Mihoko YamadaDivision of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan.
Shimpei OtsukaDivision of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan.
Yoshiyasu KatoDivision of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan.
Rui SatoDivision of Interventional Radiology Shizuoka Cancer Center Shizuoka Japan.
Akifumi NotsuClinical Research Center Shizuoka Cancer Center Shizuoka Japan.
Katsuhiko UesakaDivision of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan.
Teiichi SugiuraDivision of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan.ORCID https://orcid.org/0000-0001-7163-4084

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: This study aimed to evaluate the impact of arterial contact angle on survival outcomes in patients with borderline resectable pancreatic cancer (BRPC) undergoing neoadjuvant treatment (NAT) and surgical resection. Methods: A retrospective analysis of 84 patients with BRPC with arterial contact who underwent NAT followed by surgery at the Shizuoka Cancer Center (2012-2021) was conducted. They were classified into two groups according to the arterial contact angle measured using preoperative computed tomography: < 90° ( Results: The larger-angle group had a significantly higher R1 resection rate (28% vs. 3%, Conclusion: An arterial contact angle of ≥ 90° was associated with higher R1 resection rates, increased recurrence, and poor survival in patients with BRPC. More aggressive multimodal treatment strategies, including extended NAT, may be necessary to improve the outcomes in these high-risk patients.

Indexed as

arterial contactborderline resectable pancreatic cancerneoadjuvant therapy

Identifiers

PMID41199965
PMCPMC12586941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.